Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma

Published:2014-04 Issue:4 Volume:155 Page:640-649
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Sueoka Hideaki^ORCID,Hirano Tadamichi,Uda Yugo,Iimuro Yuji,Yamanaka Junichi,Fujimoto Jiro

Publisher

Elsevier BV

Subject

Surgery

Reference39 articles.

1. The epidemiology of cholangiocarcinoma;Shaib;Semin Liver Dis,2004

2. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line;Park;Hepatology,1999

3. Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing;Isomoto;Gastroenterology,2007

4. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells;Kobayashi;Gastroenterology,2005

5. Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest;Han;Cancer Res,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CXCR2 chemokine receptor: A new target for gastric cancer therapy;Cytokine;2024-09

2. IL-8 is a novel prometastatic chemokine in intrahepatic cholangiocarcinoma that induces CXCR2-PI3K/AKT signaling upon CD97 activation;Scientific Reports;2023-10-31

3. Therapeutic inhibition of CXCR1/2: where do we stand?;Internal and Emergency Medicine;2023-05-30

4. The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers;Cells;2023-05-17

5. Transcriptomic analysis reveals the promotion of lymph node metastasis by Helicobacter pylori infection via upregulating chemokine (C-X-C motif) receptor 2 expression in gastric carcinoma;Genes & Diseases;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3